Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05685810Active Not Recruiting

Genetic Determinants of Kidney Disease in People of African Ancestry With HIV

Role: collaborator

NCT05365828Active Not Recruiting

Legacies and Futures: Measuring Roles of Resilience and Vulnerability in Pregnancy and Birth Outcomes

Role: collaborator

NCT05432739Recruiting

Nodule IMmunophenotyping Biomarker for Lung Cancer Early Diagnosis Study

Role: collaborator

NCT04647474Completed

Mental Wellbeing and Quality of Life in Prostate Cancer

Role: collaborator

NCT04270799Unknown

Lung Nodule Imaging Biobank for Radiomics and AI Research

Role: collaborator

NCT03912142Completed

Diagnosis of Obstetric Anal Sphincter Injuries (OASIs) Using Transperineal Ultrasound Scan (TPUS)

Role: lead

All 6 trials loaded